Scott R. Pancoast Joins the Imaging3 Team
Imaging3, Inc. (OTCQB: “IGNG”) Announces Denial of Vuksich Application for Writ of Certiorari by the United States Supreme Court
Imaging3, Inc. (OTCQB: “IGNG”) Announces Execution of Consulting Service Agreement with Biologics Consulting Group, Inc.
Imaging3, Inc. (OTCQB: “IGNG”) Announces execution of agreement with CriTech Research to Complete Software Verification, Validation and Remediation for the Company’s Planned FDA 510(k) Application
Imaging3, Inc. Announces Commencement of Trading of its Common Stock on the OTCQB under Trading Symbol “IGNG”.
Imaging3, Inc. announces Notification of the Assignment of the Over-the-Counter Quoting and Trading Symbol “IGNG” for its Common Stock
Imaging3, Inc. announces it is now approved for trading.
Imaging3, Inc. Announces Completion of Outstanding Form 10-Q Quarterly Filings
Imaging3, Inc. Announces Appointment of New Board Member
Imaging3, Inc. Announces 2012-2013, 2103-2014, 10K’s completed.
Imaging3, Inc. Announces 2015 Updates
Imaging3, Inc. Announces 2015 Outlook and Updates
Imaging3 Executes Securities Purchase Agreement for Sale of Common Stock and Warrants for $1 Million